MELISSA EDGINTON: Open Payments
NPI 1093136269 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$276 in 3 payments from 3 companies in 2025. Trend: 2023 $958 · 2024 $1,937 · 2025 $276
Food & beverage: $276
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 1 | $150 |
| Janssen Biotech, Inc. | 1 | $98 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
Products named: AMVUTTRA, SPEVIGO.
Industry payments across CA — which companies pay providers there.
